Zanghì, A., Borriello, G., Bonavita, S., Fantozzi, R., Signoriello, E., Barone, S., . . . D’Amico, E. (2024). Ocrelizumab and ofatumumab comparison. Journal of Neurology, 271(7), 4495-4502. https://doi.org/10.1007/s00415-024-12360-x
Chicago-referens (17:e uppl.)Zanghì, Aurora, et al. "Ocrelizumab and Ofatumumab Comparison." Journal of Neurology 271, no. 7 (2024): 4495-4502. https://doi.org/10.1007/s00415-024-12360-x.
MLA-referens (9:e uppl.)Zanghì, Aurora, et al. "Ocrelizumab and Ofatumumab Comparison." Journal of Neurology, vol. 271, no. 7, 2024, pp. 4495-4502, https://doi.org/10.1007/s00415-024-12360-x.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
